guhjy's Di Bisceglie:AM [12 articles] Export Sort

Recent papers posted to guhjy's library by the author Di Bisceglie:AM. You can also see everyone's Di Bisceglie:AM.

Hide details

	Predicting Clinical and Histological Outcomes Based on Standard Laboratory Tests In Advanced Chronic Hepatitis C. [My Copy] Gastroenterology (17 September 2009) by Marc G. Ghany, Anna S. Lok, James E. Everhart, et al.Gregory T. Everson, William M. Lee, Teresa M. Curto, Elizabeth C. Wright, Anne M. Stoddard, Richard K. Sterling, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, Chihiro Morishima, Timothy R. Morgan, Jules L. Dienstag, HALT-C Trial Group posted to halt-c by guhjy on 2009-10-29 02:32:02 as
	Des-gamma-carboxy Prothrombin and Alpha fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma. [My Copy] Gastroenterology (20 October 2009) by Anna S. Lok, Richard K. Sterling, James E. Everhart, et al.Elizabeth C. Wright, John C. Hoefs, Adrian M. Di Bisceglie, Timothy R. Morgan, Hae-Young Y. Kim, William M. Lee, Herbert L. Bonkovsky, Jules L. Dienstag, HALT-C Trial Group posted to hcc halt-c afp by guhjy on 2009-10-29 02:31:55 as
	Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial. [My Copy] Hepatology (Baltimore, Md.), Vol. 49, No. 6. (June 2009), pp. 1828-1837. by Anna S. Lok, James E. Everhart, Raymond T. Chung, et al.Hae-Young Y. Kim, Gregory T. Everson, John C. Hoefs, Joel K. Greenson, Richard K. Sterling, Karen L. Lindsay, William M. Lee, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, Marc G. Ghany, Chihiro Morishima, HALT-C Trial Group posted to halt-c by guhjy on 2009-10-29 02:31:37 as
	Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the Halt-C Trial. [My Copy] Gastroenterology (10 September 2009) by Mitchell L. Shiffman, Chihiro Morishima, Jules L. Dienstag, et al.Karen L. Lindsay, John C. Hoefs, William M. Lee, Elizabeth C. Wright, Deepa Naishadham, Gregory T. Everson, Anna S. Lok, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, Marc G. Ghany, HALT-C Trial Group posted to hcv halt-c by guhjy on 2009-10-29 02:24:41 as
	Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial. [My Copy] Hepatology (Baltimore, Md.), Vol. 49, No. 6. (June 2009), pp. 1847-1858. by Tania Mara M. Welzel, Timothy R. Morgan, Herbert L. Bonkovsky, et al.Deepa Naishadham, Ruth M. Pfeiffer, Elizabeth C. Wright, Amy A. Hutchinson, Andrew T. Crenshaw, Arman Bashirova, Mary Carrington, Myhanh Dotrang, Richard K. Sterling, Karen L. Lindsay, Robert J. Fontana, William M. Lee, Adrian M. Di Bisceglie, Marc G. Ghany, David R. Gretch, Stephen J. Chanock, Raymond T. Chung, Thomas R. O'Brien, HALT-C Trial Group posted to halt-c by guhjy on 2009-10-29 02:19:12 as
	Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. [My Copy] Hepatology (Baltimore, Md.) (13 July 2009) by Neal D. Freedman, James E. Everhart, Karen L. Lindsay, et al.Marc G. Ghany, Teresa M. Curto, Mitchell L. Shiffman, William M. Lee, Anna S. Lok, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, John C. Hoefs, Jules L. Dienstag, Chihiro Morishima, Christian C. Abnet, Rashmi Sinha, HALT‐C Trial GroupThe HALT‐C Trial was registered with clinicaltrials.gov (#NCT00006164). posted to rct hcv halt-c coffee by guhjy on 2009-10-29 02:13:05 as
	Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients. [My Copy] Hepatology (Baltimore, Md.) (13 November 2008) by Sarah L L. George, Bruce R R. Bacon, Elizabeth M M. Brunt, Kusal L L. Mihindukulasuriya, Joyce Hoffmann, Adrian M M. Di Bisceglie posted to rx hcv by guhjy on 2008-12-19 03:42:52 as
	Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. [My Copy] The New England journal of medicine, Vol. 359, No. 23. (4 December 2008), pp. 2429-2441. by Adrian M. Di Bisceglie, Mitchell L. Shiffman, Gregory T. Everson, et al.Karen L. Lindsay, James E. Everhart, Elizabeth C. Wright, William M. Lee, Anna S. Lok, Herbert L. Bonkovsky, Timothy R. Morgan, Marc G. Ghany, Chihiro Morishima, Kristin K. Snow, Jules L. Dienstag, HALT-C Trial Investigators posted to halt-c hcv ifn rct by guhjy on 2008-12-16 11:36:58 as
	Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders [My Copy] Controlled Clinical Trials, Vol. 25, No. 5. (October 2004), pp. 472-492. by William M. Lee, Jules L. Dienstag, Karen L. Lindsay, et al.Anna S. Lok, Herbert L. Bonkovsky, Mitchell L. Shiffman, Gregory T. Everson, Adrian M. Di Bisceglie, Timothy R. Morgan, Marc G. Ghany, Chihiro Morishima, Elizabeth C. Wright, James E. Everhart posted to hcv liver rct by guhjy on 2008-06-14 02:09:16 as
	Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma [My Copy] J. Natl. Cancer Inst., Vol. 100, No. 10. (21 May 2008), pp. 698-711. by Josep M. Llovet, Adrian M. Di Bisceglie, Jordi Bruix, et al.Barnett S. Kramer, Riccardo Lencioni, Andrew X. Zhu, Morris Sherman, Myron Schwartz, Michael Lotze, Jayant Talwalkar, Gregory J. Gores, For The Panel Of Experts In hcc-Design Clinical Trials posted to hcc rct end-point by guhjy on 2008-06-09 11:15:07 as
	Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial [My Copy] Hepatology, Vol. 9999, No. 9999. (2007), NA. by Leonard B. Seeff, Teresa M. Curto, Gyongyi Szabo, et al.Gregory T. Everson, Herbert L. Bonkovsky, Jules L. Dienstag, Mitchell L. Shiffman, Karen L. Lindsay, Anna S. F. Lok, Adrian M. Di Bisceglie, William M. Lee, Marc G. Ghany, Halt-C T. Group posted to hcv herb rct silymarin by guhjy on 2007-12-29 03:27:53 as
	Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. [My Copy] Ann Intern Med, Vol. 141, No. 9. (2 November 2004), pp. 715-717. by M. J. Alter, L. B. Seeff, B. R. Bacon, D. L. Thomas, M. O. Rigsby, A. M. Di Bisceglie posted to no-tag by guhjy on 2007-09-11 04:11:48 as

Note: You may cite this page as: http://www.citeulike.org/user/guhjy/author/Di Bisceglie:AM

Sort by:
Order:	Default Ascending Descending
Empty fields:	Default First Last

ckd	1742
rct	1206
dn	1176
dm	1073
cancer	1068
ma	981
cv	936
hd	859
tgfb	857
snp	773
ros	707
bp	645
kidney	533
meta-analysis	516
mouse	509
uae	501
stats	480
software	468
pt	458
mirna	450
genetics	450
proteomics	414
mortality	411
rat	402
1	391
fbl	386
tw	378
inflammation	378
mtor	364
proteinuria	356
pcr	356
mc	351
akt	351
acei	340
method	340
db	337
irs	333
gdl	332
inhibitor	329
test	325
apoptosis	321
urine	320
age	318
arb	318
aging	315
ms	314
aii	310
hcv	308
r	297
hg	293
biomarker	288
pi3k	284
ppi	282
bias	278
bayes	275
aki	272
gwa	271
emt	268
s6k	266
rnai	257
egfr	256
nutrition	255
ub	248
p53	246
fibrosis	242
erk	238
obesity	237
smad	234
cox	229
drug	225
pbmc	223
hcc	217
hypoxia	216
metab	215
gn	210
nfkb	209
herb	205
stz	199
collagen	197
albumin	189
hif	187
lc	187
pkc	181
pubmed	179
longitudinal	179
lmm	178
p38	176
gfr	175
ua	171
epigenetics	169
book	168
bioinf	167
japan	166
cea	163
power	163
dna-damage	162
rage	162
gender	162
lead	160
cadmium	159
genomics	156
ref	152
ctgf	150
vitamin-d	149
liver	147
stata	147
mt	146
network	146
company	146
diet	138
insulin	137
screening	137
rt	136
phosphorylation	135
seq	133
no	132
stat	130
go	128
kinase	128
cell-cycle	128
esrd	128
pathway	127
protein	127
systems-biology	124
statin	121
lipid	119
creatinine	117
proliferation	113
senescence	112
podocyte	111
imaging	110
gene-therapy	110
nox	109
mapk	109
tnf	107
hypertrophy	105
fish	104
p21	104
pparg	104
cad	103
regression	103
pd	102
case-control	102
gfr-formula	102
imputation	101
ampk	100
multiplicity	100
at1	98
plasmid	98
observational	98
sirt	97
ko	97
methylation	96
rx	96
pediatric	96
cloning	96
recurrent	94
blood	93
src	93
betel	93
review	92
chf	92
nhanes	91
website	91
immunity	89
anemia	89
phenotype	88
autophagy	87
diagnosis	87
lr	86
toxicology	86
uti	85
epo	85
cytokine	84
ebm	84
ca	83
p	83
china	83
environment	82
nonp	81
oat	81
cachexia	81
gout	80
hapmap	80
qms	78
primer	78
signaling	76
foxo	74
col4	74
egf	74
promoter	74
missing	73
ace	73
gpcr	73
eif	73
gene-list	72
cox2	72
stone	72
hts	72
4ebp	72
eqtl	72
surrogate	72
lpd	72
p-value	71
mv	71
mgo	70
jnk	70
salt	70
metformin	70
phd	70
glycemia	69
uuo	67
tin	67
uncertainty	66
fluorescence	66
normalization	66
mirna-target	65
enddysf	65
ifn	65
chinese	65
translation	65
pe	65
shc	64
hsp	64
pla2	64
association	64
llcpk1	63
yeast	63
2dge	63
acid-base	63
causation	63
oglcnac	62
simulation	62
pdgf	62
pai1	62
smoking	62
me	62
nrk49f	62
ptm	61
avf	61
vegf	61
confounding	61
mmp	61
sas	60
infection	60
pld	60
outcome	60
hk2	60
change	60
cost	60
crp	60
melamine	60
oral	60
alcohol	58
iron	58
rho	58
cyclin-d1	57
model-selection	57
pls	57
robust	57
urate-transporter	57
rapamycin	57
achr	56
calibration	56
semantic	56
aceiarb	56
ace2	55
ratio	55
competing-risk	55
goldstd	55
stem-cell	55
ncrna	55
estrogen	55
function	54
bone	54
ckd-progression	54
workflow	54
p27	53
k	53
hsc	53
renoprotection	53
il6	53
dipstick	53
std	53
dimerization	52
hdac	52
histone	52
fgf	52
qc	52
tf	52
atm	52
normoalbuminuria	51
ab	51
hepatocyte	51
epidemiology	51
lod	51
pth	51
mercury	50
graph	50
wnt	50
arsenic	50
risk-ratio	50
matlab	50
adpkd	50
reasoning	50
klotho	49
epistasis	49
antibiotics	49
biosensor	49
pdk	49
gene-environment	49
ngal	48
ffpe	48
endothelium	48
breakpoint	48
ukm	48
irs1	48
nrk52e	48
core-curriculum	48
ras	47
mtorc1	47
pooling	47
enos	47
spot-urine	47
joint-model	47
aldosterone	47
metal	46
cystatin	46
hgf	46
aspirin	46
protein-microarray	46
fdr	46
dub	46
er-stress	46
tgfbr	45
semip	45
fgf23	45
ecm	45
writing	45
prevention	45
dbdb	45
interaction	44
mesangial	44
diuretics	44
cnv	44
sumo	44
variability	44
ancova	44
ccb	44
bia	43
klf	43
design	43
sle	43
na	43
fibronectin	42
stroke	42
vsmc	42
icu	42
good	42
agreement	42
catenin	42
asia	42
bmi	42
roc	42
qtl	41
gene-targeting	41
proteasome	41
fuzzy	41
tlr	40
rca	40
ap1	40
hyperfiltration	40
sage	40
wga	40
tea	40
risk	40
alignment	40
glut	39
dry-bw	39
omics	39
igf	39
rsk	39
antisense	39
coffee	39
protein-complex	39
urinalysis	39
angiogenesis	39
gsk3	38
igan	38
emr	38
mtorc2	38
rvh	38
myc	38
snx	38
megalin	37
adh	37
hematuria	37
bh4	37
fabp	37
haplotype	37
gsk	37
propensity	37
adenosine	37
animal	36
s100b	36
exercise	36
web20	36
il1	36
inflammasome	36
cardiorenal	36
nephrotoxicity	36
calcification	35
cre	35
creb	35
sp1	35
pka	35
annotation	35
adduct	35
subgroup	35
reverse-epidemiology	35
threshold	35
chemogenomics	35
candidate-gene	35
sglt	35
igf1	34
msm	34
pathology	34
sepsis	34
attrition	34
pp2a	34
effect-size	34
cross-species	34
browser	33
rtk	33
et	33
zeb	33
integrin	33
cage	33
ns	33
sarcopenia	33
ecology	33
bmp	33
aa	32
end-point	32
set	32
macrophage	32
agt	32
steroid	32
zfn	32
addgene	32
orbitrap	32
transactivation	32
ai	32
affy	32
fc	32
text-mining	32
acidosis	31
frailty	31
heritability	31
hospitalization	31
family	31
nutrient	31
blast	31
reporter	31
emsa	31
cr	31
abp	31
gllamm	31
silac	31
risk-difference	31
gsh	31
notch	30
pten	30
grn	30
membrane-protein	30
s100	30
renin	30
transporter	30
mw	30
staging	30
knockout	30
geo	30
carcinogen	30
human	30
validation	29
extraction	29
3	29
virus	29
perindopril	29
ub-ligase	29
sgk	29
nicotinic	29
thesis	29
scaling	28
hplc	28
jun	28
mutagenesis	28
race	28
time-dependent	28

guhjy's Di Bisceglie:AM [12 articles] Export Sort

guhjy's tags